This reclassification accounted for 467 variants due to an MAF > 0.5% for AR or MAF > 0.1% for AD, 134 variants due to relatively high MAF combined with benign computational predictions, 35 AD‐associated variants detected in multiple CDGC controls, and 4 variants based on other combined evidence. This evidence concerns the gene AR and Alzheimer disease.